Please login to the form below

Not currently logged in
Email:
Password:

SEC

This page shows the latest SEC news and features for those working in and with pharma, biotech and healthcare.

Lilly ends $1.4bn deal with immuno-oncology biotech NextCure

Lilly ends $1.4bn deal with immuno-oncology biotech NextCure

NextCure did not reveal why Lilly decided to terminate the agreement, saying in a brief US Securities and Exchange Commission (SEC) filing:. ... Shares in the biotech fell shortly after the SEC filing was released – the company is also due to present

Latest news

More from news
Approximately 2 fully matching, plus 63 partially matching documents found.

Latest Intelligence

  • Creating a successful global compliance programme Creating a successful global compliance programme

    The importance of effective compliance programmes was highlighted in the DOJ and SEC’s Resource Guide to the US Foreign Corrupt Practices Act, which describes in detail the hallmarks of a

  • Deal Watch January 2018

    However, in the meantime the US Securities and Exchange Commission (SEC) has issued a lawsuit against some traders for insider trading based on a series of suspicious transactions that made about

  • US health reforms US health reforms

    In March, the Securities and Exchange Commission (SEC) only narrowly blocked this move.

  • Deal Watch - May 2017 Deal Watch - May 2017

    A good example is Abbott’s acquisition of the diagnostics company Alere signed in February 2016.  Two months later Abbott asked Alere to cancel the transaction because of a SEC inquiry ... into accounting issues at Alere and offered $30m to $50m

  • On the road with the millennial HCP On the road with the millennial HCP

    Yeah I'll put Andy on. Just hang on a sec, he's just sorting our next lift.”.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • SALES ACCELERANT

    We help companies to engage prim/sec care healthcare professionals more efficiently and effectively to drive sales growth.

  • SEC Pharma

    Analysis, SEC can assist wherever you are looking to hire or work throughout the UK and Europe.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....